Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGF2BP3 pseudogene 2 (IGF2BP3P2) is a non-coding pseudogene related to the insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) family[1]. Unlike the functional IGF2BP3 gene, which encodes an RNA-binding protein implicated in cancer and other pathologies, IGF2BP3P2 does not produce a functional protein, and there are no known biological or clinical functions, disease roles, or drug interactions for this pseudogene. Its presence may be detected in genomic assays, but it is not considered a therapeutic target. If you meant the **functional gene IGF2BP3 (Insulin-like growth factor 2 mRNA-binding protein 3)**, please clarify, as this is a well-studied oncogenic RNA-binding protein with known roles in tumor biology and is a subject of therapeutic interest[1][2][3][4][5]. However, IGF2BP3P2 specifically refers to an inactive pseudogene and not a therapeutic target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IGF2BP3 pseudogene 2 (IGF2BP3P2).